Nestec S.a.

Beth Israel Deaconess Medical Center, Inc.

Societe Des Produits Nestle S.a.

Manuel Oliveira

Frederic Destaillats

Fabiola Dionisi

Cristina Cruz-Hernandez

Julie Moulin

Isabelle Masserey-Elmelegy

Bruce R Bistrian

Jalil Benyacoub

Viral Brahmbhatt

Frédéric Destaillats

Mohamed Nabil Bosco

Julie Céline Moulin

The present invention relates generally to the field of lipids and in particular aims at improving lipid absorption, for example under conditions of lipid maldigestion or malabsorption. One embodiment of the present invention relates to a composition comprising a sn-2 monoacylglycerol derivative, wherein the sn-1 and sn-3 positions are blocked by protective groups. The acyl group may be a fatty acid, for example one with anti-inflammatory properties.

Sn-2-monoacylglycerols and lipid malabsorption

Sn-2-monoacylgycerols and lipid malabsorption

The present invention relates generally to the field of lipids and in particular aims at improving lipid absorption, for example under conditions of lipid maldigestion or malabsorption. One embodiment of the present invention relates to a composition comprising sn-1(3) monoacylglycerols, wherein the sn-1 or sn-3 position is occupied by an acyl group such as a fatty acid and the sn-2 position remains unoccupied. The fatty acid may be one with anti-inflammatory properties.

Sn-1(3) monoacylglycerides and lipid absorption

Growing community of inventors

Chexbres, Switzerland

Manuel Oliveira